Production of nitro-benzyl-dota via direct peptide cyclization

Details Production of nitro-benzyl-dota via direct peptide cyclization Production of nitro-benzyl-dota via direct peptide cyclization

1995-12-13

1998-12-08

Datlow, Philip I.

Organic compounds -- part of the class 532-570 series

Organic compounds

Unsubstituted hydrocarbyl chain between the ring and the -c-...

C07D25702

Patent

active

058471219

ABSTRACT:
Methods, compounds, compositions and kits that relate to pretargeted delivery of diagnostic and therapeutic agents are disclosed. In particular, methods for radiometal labeling of biotin, as well as related compounds, are described. Articles of manufacture useful in pretargeting methods are also discussed.

REFERENCES:
patent: 4639365 (1987-01-01), Sherry
patent: 4647447 (1987-03-01), Gries et al.
patent: 4678667 (1987-07-01), Meares et al.
patent: 4775745 (1988-10-01), Ford et al.
patent: 4833251 (1989-05-01), Musso et al.
patent: 4863713 (1989-09-01), Goodwin et al.
patent: 4867973 (1989-09-01), Goers et al.
patent: 4895955 (1990-01-01), Ford et al.
patent: 4898951 (1990-02-01), Symons
patent: 4923985 (1990-05-01), Gansow et al.
patent: 5141966 (1992-08-01), Porath
patent: 5225353 (1993-07-01), Berenson et al.
patent: 5246692 (1993-09-01), Gansow et al.
patent: 5256395 (1993-10-01), Barbet et al.
Chemical Abstracts, vol. 106, No. 8, Feb. 23, 1987, Abstract No. 55742f, Van Der Sluijs.
P. van der Sluijs et al, Hepatology, "Drug Targeting to the Liver with Lactosylated Albumins: Does the Glycoprotein Target the Drugs or is it the Drugs Targeting the Glycoprotein?", vol. 6, No. 4, 1986, pp. 723-728.
Sheldon et al., Appl. Radiat. Isot., vol. 43, No. 11, pp. 1399-1402, 1992, Cells Using Covalent Monoclonal Antibody-Streptavidin Conjugates".
Goodwin, J. Nucl. Med., vol. 33, No. 10, pp. 1816-1818, 1992, "New Methods for Localizing Infection: A role for Avidin-Biotin?".
Goodwin, et al., J. Nucl. Med., vol. 33, No. 11, pp. 2006-2013, 1992, "Pretargeted Imunoscintigraphy: Effect of Hapten Valency on Murine Tumor Uptake".
McMurray et al., Bioconjugate Chem., vol. 3, No. 2, pp. 108-117, 1992, "Convenient Synthesis of Bifunctional Tetraaza Macrocycles".
Renn and Meares, Bioconjugate Chem., vol. 3, No. 6, pp. 563-569, 1992, "Large-Scale Synthesis of the Biofunctional Chelating Agent 2-(p-Nitrobenzyl)-1,4,7,10-tetraazacyclododecane-N,N',N",N'"-tetraacetic Acid, and the Determination of Its Enatiomeric Purity by Chiral Chromatography".
Koch and Macke, Angew. Chem. Intl. Ed. Engl., vol. 31, No. 11, pp. 1507-1509, 1992, ".sup.99m Tc Labeled Biotin Conjugate in a Tumor `Pretargeting` Approach with Monoclonal Antibodies".
Moi and Meares, J. Am. Chem. Soc., vol. 110, pp. 6266-6267, 1988, "The Peptide Way to Macrocyclic Bifunctional Chelating Agents: Synthesis of 2-(p-Nitrobenzyl)-1,4,7,10-tetraazacyclododecane-N,N'-N",N'"-tetraacetic Acid and Study of Its Yttrium (III) Complex". Radiolabeling Biotin," Nucl. Med. Biol., vol. 19, No. 3, pp. 297-301, 1992. Kinetic Studies and for Assay".
Kalofonos et al., J. Nucl. Med., vol. 31, No. 11, pp. 1791-1796, 1990, "Imaging of Tumor in Patients with Indium-111-Labeled Biotin and Streptavidin-Conjugated Antibodies: Preliminary Communication".
Hnatowish et al., J. Nucl. Med., vol. 28, No. 8, pp. 1294-1302, 1987, "Investigations of Avidin and Biotin for Imaging Applications".
Paganelli et al., Nuclear Medicine Communications, 12:211-234, 1991, "Monoclonal antibody pretargeting techniques for tumour localization: the avidin-biotin system".
Goodwin/Hnatowich, J. Nucl. Med., vol. 32, No. 4, pp. 750-751, 1991, Letter to the Editor/Reply.
Rosebrough, J. Nucl. Med., p. 880, 1992, Abstract No. 235, "Plasma Stability and Pharmacokinetics of Radio-Labeled Deferoxamine-Biotin Derivatives".
Virzi et al., J. Nucl. Med., p. 920, 1992, Abstract No. 403, "The Preparation and Evaluation of 12 Biotin Derivatives Labeled with Tc-99M".
Rosario et al., J. Nucl. Med., vol. 32, No. 5, p. 993, 1991, Abstract No. 356, "Bolton-Hunter and Biotin Derivatized Polylysine: A New Multi-Valent Peptide Reagent for In Vivo Pre-Targeting with Streptavidin Conjugates".
Virzi et al., Nucl. Med. Biol., "New Indium-111 Labeled Biotin Derivatives for Improved Immunotargeting", vol. 18, No. 7, pp. 719-726, 1991. Studies and for Assay".
Paganelli et al., "Intraperitoneal Radio-Localization of Tumors Pre-Targeted by Biotinylated Monoclonal Antibodies", Int. J. Cancer, 45:1184-1189, 1990.
Evangelatos et al., "Biotinidase Radioassay Using an .sup.125 I-Biotin Derivative, Avidin, and Polyethylene Glycol Reagents", Analytical Biochemistry, 196:385-389, 1991.
Horsburg and Gompertz, "A Protein-Binding Assay for Measurement of Biotin in Physiological Fluids", Clinica Chimica Acta., 82:215-223, 1978.
Best, University of Cincinnati, "Studies of Some technetium Complexes of Relevance to Nuclear Medicine", 1990.
Konrad et al, "The Immune System as a Barrier to Delivery of Protein Therapeutics", In Biological Barriers to Protein Delivery, K. L. Audus and T. I. Raub Eds., Plenum Press, NY 1993.
Spooner et al, TIBTECH, 1990, 8:189.
Rakestraw et al., "Antibody-targeted photolysis: In Vitro studies with Sn(IV) chlorine 6 covalently bound to monoclonal antibodies using modified dextran carrier", Proc. Natl. Acad. Sci., vol. 87, pp. 4217-4221, 1990.
Devanathan et al., "Readily available fluorescein isothiocyanate-conjugated antibodies can be easily converted into targeted phototoxic agents for antibacterial, antiviral, and anticancer therapy", Proc. Natl. Acad. Sci., vol. 87, pp. 2980-2984, 1990.
Bignami et al., "N-(4'-Hydroxyphenylacetyl)palytoxin: A Palytoxin Prodrug That can be Activated by a Monoclonal Antibody-Penicillin G Amidase Conjugate", Cancer Research, vol. 52, pp. 5759-5764, 1992.
Wu et al., Nucl. Med. Biol. Int. J. Tadiat. Appl. Instrum. Part B, vol. 19, No. 2, pp. 239-244, 1992, "Investigations of N-Linked Macrocycles for .sup.111 In and .sup.90 Y Labeling of Proteins".
Goodwin et al., J. Nucl. Med., p. 880, 1992, Abstract No. 232, "Pharmacokinetics of Biotin-Chelate Conjugates for Pretargeted Avidin-Biotin Immunoscintigraphy".
Dischino et al., Inorg. Chem., vol. 30, pp. 1265-1269, 1992, "Synthesis of Nonionic Gadolinium Chelates Useful as Contrast Agents for Magnetic Resonance Imaging".
Sieving et al., Bioconjugate Chem., vol. 1, pp. 65071, 1990, "Preparation and Characterization of Paramagnetic Polychelates and Their Protein Conjugates".
Parker et al., Pure & Appl. Chem., vol. 61, No. 9, pp. 1637-1641, 1989, "Implementation of macrocyclic conjugated antibodies for tumor-targeting".
Riesen et al., J. Chem. Soc., Chem. Commun., pp. 460-462, 1989, "Synthesis and X-Ray Structural Characterization of Seven Co-ordinate Macrocyclic In .sup.3+ Complexes with Relevance to Radiopharmaceutical Applications".
Kasprzyk and Wilkins, Inorg. Chem., "Kinetics of Interaction of Metal Ions with Two Tetraaza Tetraacetate Macrocycles", vol. 21, pp. 3349-3352, 1982.
International Search Report for PCT Patent Application No. PCT/US93/05406.
Jain, Scientific American, 271:58, 1994.
Curti, Crit. Rev. Onco./Hematol., 14:29, 1993.
The Merck Index, p. 188, Compound 1226, 1983.
Foon et al, Cancer Res., 1989, 49:1621.
Amato, "Hope for a Magic Bullet that Moves at the Speed of Light", Science, vol. 262, pp. 32-33, Oct. 1, 1993.
Kreimer-Birnbaum, "Modified Porphyrins, Chlorins, Phthalocyanines, and Purpurins: Second Generation Photosensitizers for Photodynamic Therapy", Seminars in Hematology, vol. 26, No. 2 (Apr.), pp. 157-173, 1989.
Pass, "Photodynamic Therapy Oncology: Mechanisms and Clinical Use", J. of the Natl. Cancer Institute, vol. 85, No. 6, pp. 443-456, 1993.
Herman et al., "Synthesis of Dextran Derivatives with Thiol-Specific Reactive Groups for the Preparation of Dextran-Protein Conjugates", Bioconjugate Biochem., vol. 4, pp. 402-405, 1993.
Goff et al., "Photoimmunotherapy of Human Ovarian Carcinoma Cells Ex Vivo", Cancer Research, vol. 51, pp. 4762-4767, 1991.
Burrows and Thorpe, "Eradication of large solid tumors in mice with an immunotoxin directed against tumor vasculature", Proc. Natl. Acad. Sci., vol. 90, pp. 8996-9000, 1993.

Affiliated with

Also associated with

Rating

Production of nitro-benzyl-dota via direct peptide cyclization does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Production of nitro-benzyl-dota via direct peptide cyclization, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Production of nitro-benzyl-dota via direct peptide cyclization will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-178628